404 related articles for article (PubMed ID: 16041556)
1. Treatment of neuroendocrine cancer metastatic to the liver: the role of ablative techniques.
Atwell TD; Charboneau JW; Que FG; Rubin J; Lewis BD; Nagorney DM; Callstrom MR; Farrell MA; Pitot HC; Hobday TJ
Cardiovasc Intervent Radiol; 2005; 28(4):409-21. PubMed ID: 16041556
[TBL] [Abstract][Full Text] [Related]
2. Liver-directed therapies for metastatic neuroendocrine tumors.
Garrot C; Stuart K
Hematol Oncol Clin North Am; 2007 Jun; 21(3):545-60; ix-x. PubMed ID: 17548039
[TBL] [Abstract][Full Text] [Related]
3. Improved outcome with cytoreduction versus embolization for symptomatic hepatic metastases of carcinoid and neuroendocrine tumors.
Osborne DA; Zervos EE; Strosberg J; Boe BA; Malafa M; Rosemurgy AS; Yeatman TJ; Carey L; Duhaine L; Kvols LK
Ann Surg Oncol; 2006 Apr; 13(4):572-81. PubMed ID: 16511671
[TBL] [Abstract][Full Text] [Related]
4. Radiofrequency ablation of liver cancer.
Lencioni R; Crocetti L
Tech Vasc Interv Radiol; 2007 Mar; 10(1):38-46. PubMed ID: 17980317
[TBL] [Abstract][Full Text] [Related]
5. Thermal ablative therapies for secondary hepatic malignancies.
Mayo SC; Pawlik TM
Cancer J; 2010; 16(2):111-7. PubMed ID: 20404607
[TBL] [Abstract][Full Text] [Related]
6. Technology insight: Image-guided therapies for hepatocellular carcinoma--intra-arterial and ablative techniques.
Hong K; Georgiades CS; Geschwind JF
Nat Clin Pract Oncol; 2006 Jun; 3(6):315-24. PubMed ID: 16757969
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic alternatives in metastatic neuroendocrine tumors.
Miller CA; Ellison EC
Surg Oncol Clin N Am; 1998 Oct; 7(4):863-79. PubMed ID: 9735138
[TBL] [Abstract][Full Text] [Related]
8. Management of advanced neuroendocrine tumors with hepatic metastasis.
Khasraw M; Gill A; Harrington T; Pavlakis N; Modlin I
J Clin Gastroenterol; 2009 Oct; 43(9):838-47. PubMed ID: 19654558
[TBL] [Abstract][Full Text] [Related]
9. The role of focal liver ablation in the treatment of unresectable primary and secondary malignant liver tumors.
Gannon CJ; Curley SA
Semin Radiat Oncol; 2005 Oct; 15(4):265-72. PubMed ID: 16183480
[TBL] [Abstract][Full Text] [Related]
10. Cryoablation, percutaneous alcohol injection, and radiofrequency ablation for treatment of neuroendocrine liver metastases.
Siperstein AE; Berber E
World J Surg; 2001 Jun; 25(6):693-6. PubMed ID: 11376399
[TBL] [Abstract][Full Text] [Related]
11. Hepatic cytoreduction followed by a novel long-acting somatostatin analog: a paradigm for intractable neuroendocrine tumors metastatic to the liver.
Chung MH; Pisegna J; Spirt M; Giuliano AE; Ye W; Ramming KP; Bilchik AJ
Surgery; 2001 Dec; 130(6):954-62. PubMed ID: 11742323
[TBL] [Abstract][Full Text] [Related]
12. Radiofrequency ablation of neuroendocrine liver metastases: the Middlesex experience.
Gillams A; Cassoni A; Conway G; Lees W
Abdom Imaging; 2005; 30(4):435-41. PubMed ID: 15759207
[TBL] [Abstract][Full Text] [Related]
13. Metastatic neuroendocrine hepatic tumors: resection improves survival.
Musunuru S; Chen H; Rajpal S; Stephani N; McDermott JC; Holen K; Rikkers LF; Weber SM
Arch Surg; 2006 Oct; 141(10):1000-4; discussion 1005. PubMed ID: 17043278
[TBL] [Abstract][Full Text] [Related]
14. A primer on transarterial, chemical, and thermal ablative therapies for hepatic tumors.
Garrean S; Hering J; Helton WS; Espat NJ
Am J Surg; 2007 Jul; 194(1):79-88. PubMed ID: 17560915
[TBL] [Abstract][Full Text] [Related]
15. [Interventional therapy of neuroendokrine tumors of the gastrointestinal tract].
Kettenbach J; Müller SL; Schindl M
Wien Klin Wochenschr; 2003; 115 Suppl 2():56-64. PubMed ID: 15518148
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous image-guided radiofrequency ablation of liver tumors.
Lencioni R; Crocetti L; Pina MC; Cioni D
Abdom Imaging; 2009; 34(5):547-56. PubMed ID: 19030918
[TBL] [Abstract][Full Text] [Related]
17. Cryoablation for liver cancer.
Hinshaw JL; Lee FT
Tech Vasc Interv Radiol; 2007 Mar; 10(1):47-57. PubMed ID: 17980318
[TBL] [Abstract][Full Text] [Related]
18. Hepatic arterial chemoembolization using drug-eluting beads in gastrointestinal neuroendocrine tumor metastatic to the liver.
Gaur SK; Friese JL; Sadow CA; Ayyagari R; Binkert CA; Schenker MP; Kulke M; Baum R
Cardiovasc Intervent Radiol; 2011 Jun; 34(3):566-72. PubMed ID: 21431978
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcome after chemoembolization and embolization of hepatic metastatic lesions from neuroendocrine tumors.
Ho AS; Picus J; Darcy MD; Tan B; Gould JE; Pilgram TK; Brown DB
AJR Am J Roentgenol; 2007 May; 188(5):1201-7. PubMed ID: 17449759
[TBL] [Abstract][Full Text] [Related]
20. Interstitial ablative techniques for hepatic tumours.
Erce C; Parks RW
Br J Surg; 2003 Mar; 90(3):272-89. PubMed ID: 12594662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
